Search for: "ACTAVIS" Results 861 - 880 of 1,010
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
23 Feb 2010, 5:05 am
Cross-checking his conclusion using the European Patent Office's problem-solution approach discussed by Lord Justice Jacob in his recent judgment in Actavis v Novartis (noted here by the IPKat, in what is this weblog's all-time most commented-upon post), Arnold J concluded that the skilled team of researchers could have solved the problem before them without needing to look beyond the relevant prior art, so obviousness was proved.This judgment is far too long for the IPKat to… [read post]
21 Feb 2010, 1:45 am
 This is a particularly interesting one for the IPKat, because it was his announcement of the referral being made back in May 2008 that apparently resulted in an unusual postscript being added to the Court of Appeal's judgment in Actavis v Merck (IPKat commentary here, decision in full here). [read post]
18 Feb 2010, 4:30 am by By DEALBOOK
Actavis has severed ties with Sweden's EQT in a bid for German drug maker Ratiopharm, Reuters reported. [read post]
17 Feb 2010, 2:02 pm
This particular Kat was busy digesting the Court of Appeal's decision in Actavis v Novartis when another part of the IPKat commented on it here. [read post]
17 Feb 2010, 9:33 am by michael
Supreme Court Tomlinson & Ors v Birmingham City Council [2010] UKSC 8 (17 February 2010) Court of Appeal (Civil Division) Harley & Ors v Smith & Anor [2010] EWCA Civ 78 (17 February 2010) Actavis UK Ltd v Novartis AG [2010] EWCA Civ 82 (17 February 2010) Davies & Anor, R (on the application of) v HM Revenue & Customs [2010] EWCA Civ 83 (16 February 2010) Virdi v The Law Society of England and Wales & Anor [2010] EWCA Civ 100 (16 February 2010) Smith v Youth Justice… [read post]
17 Feb 2010, 6:09 am
Readers with good memories may recall the decision of Mr Justice Warren (Patents Court, England and Wales) in Actavis v Novartis [2009] EWHC 41 (Ch) (noted briefly by the IPKat here) concerning the validity of Novartis's European patent EP0948320 which claimed a sustained release formulation for fluvastatin, a drug intended to prevent heart attacks caused by high cholesterol. [read post]
14 Feb 2010, 4:20 pm by Aaron Barkoff
Actavis Elizabeth LLC, et al., No. 07-3770-DMC (D.N.J. 2009) Two recent cases illustrate how owners of pharmaceutical method-of-use patents may find themselves walking a tightrope when their patents are attacked simultaneously on enablement and obviousness grounds. [read post]
11 Feb 2010, 11:22 am by Beck, et al.
Actavis, Inc., ___ F.3d ___, 2010 WL 46513 (5th Cir. [read post]
27 Jan 2010, 9:20 pm by Walter Olson
District Judge Joseph Goodwin plans to punish lawyers who filed worthless claims against Mylan Pharmaceuticals and Actavis Totowa. [read post]
27 Jan 2010, 9:09 pm by Walter Olson
District Judge Joseph Goodwin plans to punish lawyers who filed worthless claims against Mylan Pharmaceuticals and Actavis Totowa. [read post]
27 Jan 2010, 3:00 am
Aurobindo Pharma Limited (Patentcircle) India/US: Indian pharma sector ‘fares well’ in US disputes (PatLit) India: The woes of the grassroot innovator in the agricultural sector (Spicy IP) South Africa: Biopiracy in Alice – Schwabe Pharamaceuticals wishes to patent method for extracting active ingredient in cough medicine from pelargonium roots (Afro-IP) UK: Okay to split costs where actions are joined, says Court of Appeal: Actavis UK Ltd v Eli Lilly & Co Ltd (PatLit)… [read post]
19 Jan 2010, 12:00 am
To round out the picture, in a slightly more expected vein (read completely expected) was the Eli Lilly V Actavis (Strattera case). [read post]
14 Jan 2010, 11:09 am by Guest Barista
Actavis Elizabeth LLC, 2-07-cv-03770 (NJD December 31, 2009, Amended Opinion (Cavanaugh, J.). [read post]
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle)   Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement complaint against Cobrek in N D… [read post]
12 Jan 2010, 7:26 am by Dennis Crouch
Actavis Elizabeth LLC, --- F.Supp.2d ----, 2009 WL 5159650 (D.N.J. 2009)("The actions of the doctors and patients will be treated together, and will be considered a directly infringing act. [read post]
6 Jan 2010, 3:32 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Wellbutrin (Bupropion) – US: An employee benefit plan files motion to certify class action against Biovail and GlaxoSmithKline alleging companies conspired to delay generic Wellbutrin by filing baseless patent suits (GenericsWeb) Emend (Fosaprepitant dimeglumine) – US: FDA issues exclusivity decision for Merck’s… [read post]
4 Jan 2010, 8:19 pm by Angel Reyes
  Fentanyl pain patches are also sold by Mylan, Watson and Actavis. [read post]